Literature DB >> 5111740

Clinical trials with adriamycin.

E Middleman, J Luce, E Frei.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5111740     DOI: 10.1002/1097-0142(1971)28:4<844::aid-cncr2820280407>3.0.co;2-9

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  30 in total

1.  Metabolism of daunorubicin by a barbiturate-sensitive aldehyde reductase from rat liver.

Authors:  A J Turner; P E Hick
Journal:  Biochem J       Date:  1976-12-01       Impact factor: 3.857

2.  Illuminating anthracycline cardiotoxicity: the renaissance of evidence-based onco-cardiology.

Authors:  Isaac B Rhea; Guilherme H Oliveira
Journal:  J Thorac Dis       Date:  2015-07       Impact factor: 2.895

3.  Past, present, and future challenges in breast cancer treatment.

Authors:  George W Sledge; Eleftherios P Mamounas; Gabriel N Hortobagyi; Harold J Burstein; Pamela J Goodwin; Antonio C Wolff
Journal:  J Clin Oncol       Date:  2014-06-02       Impact factor: 44.544

4.  Dexrazoxane Significantly Reduces Anthracycline-induced Cardiotoxicity in Pediatric Solid Tumor Patients: A Systematic Review.

Authors:  Kelly Liesse; Jamie Harris; Megan Chan; Mary L Schmidt; Bill Chiu
Journal:  J Pediatr Hematol Oncol       Date:  2018-08       Impact factor: 1.289

5.  The kinetics of blood brain barrier permeability and targeted doxorubicin delivery into brain induced by focused ultrasound.

Authors:  Juyoung Park; Yongzhi Zhang; Natalia Vykhodtseva; Ferenc A Jolesz; Nathan J McDannold
Journal:  J Control Release       Date:  2012-06-15       Impact factor: 9.776

6.  Prevention of doxorubicin-induced alopedia by scalp hypothermia: relation to degree of cooling.

Authors:  R P Gregory; T Cooke; J Middleton; R B Buchanan; C J Williams
Journal:  Br Med J (Clin Res Ed)       Date:  1982-06-05

7.  Adriamycin cardiotoxicity: report of an unusual case with features resembling endomyocardial fibrosis.

Authors:  W Fitter; D J deSa; K R Pai
Journal:  J Clin Pathol       Date:  1981-06       Impact factor: 3.411

8.  Cardiomyopathy in leukemia, with reference to rubidomycin cardiotoxicity.

Authors:  B Lantz; J Adolfsson; B Lagerlöf; P Reizenstein
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

9.  Adriamycin and daunorubicin inhibition of mutant T4 DNA polymerases.

Authors:  M F Goodman; M J Bessman; N R Bachur
Journal:  Proc Natl Acad Sci U S A       Date:  1974-04       Impact factor: 11.205

10.  Minimization of inflammation in the treatment of bladder tumors by intravesical instillation of adriamycin.

Authors:  Y Ohi; K Okamoto; T Kawabata; A Hanafusa; C Y Fai; T Kakinoki; M Kawahara; S Asechi; N Sakamoto; S Nagata
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.